The post Tesla stock set for more pain after major bearish exposure appeared on BitcoinEthereumNews.com. Shares of Tesla (NASDAQ: TSLA) may be facing further downsideThe post Tesla stock set for more pain after major bearish exposure appeared on BitcoinEthereumNews.com. Shares of Tesla (NASDAQ: TSLA) may be facing further downside

Tesla stock set for more pain after major bearish exposure

2026/03/16 21:58
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.

Shares of Tesla (NASDAQ: TSLA) may be facing further downside pressure after the stock closed below a key technical level.

At the close of markets on Friday, TSLA shares were valued at $391, down almost 1% for the day. Year to date, the stock has plunged more than 10%.

The latest move marks Tesla’s drop below the closely watched 200-day moving average (MA) for the first time since September, signaling weakening long-term momentum.

Tesla stock price analysis chart. Source: Barchart

The breakdown comes after the stock has already fallen more than 20% from its December all-time high, a decline that places Tesla firmly in bear-market territory by traditional market definitions.

Notably, the 200-day moving average is a widely used indicator to gauge a stock’s long-term trend. Trading above it typically signals strong bullish momentum and institutional support, while a move below it often points to a broader downtrend.

Tesla shares have been declining since peaking in late December, forming lower highs and lower lows through January and February. The latest candles show the price breaking below the rising 200-day average near the $395–$400 zone, a level that previously acted as support. 

Although the stock briefly dipped below this level in early September before rebounding, the current setup appears more fragile, as the broader pullback and persistent selling pressure suggest the potential for a deeper decline rather than a short-term shakeout.

Tesla’s bearish pressure

Overall, the electric vehicle giant has faced renewed pressure, extending a multi-week decline as investors weigh slowing core auto sales against ambitious bets on autonomy and humanoid robots.

For instance, in China, Tesla’s made-in-China EV sales rose more than 35% year over year in the first two months of 2026, reaching 127,728 units and outperforming rivals such as BYD, whose figures declined during the same period. This provides a bright spot in what remains a challenging global EV market.

However, analysts have sharply cut 2026 delivery growth forecasts, with some now predicting a third consecutive year of declining deliveries amid intensifying competition and margin pressures.

Tesla’s strategic pivot includes heavy investment, more than $20 billion planned in capital expenditures, toward artificial intelligence, robotaxis, and the Optimus humanoid robot.

Recent highlights include showcasing the upcoming Gen 3 Optimus at AWE 2026 in Shanghai, with mass production targeted by the end of the year, alongside public displays of the company’s Cybercab concept at various events. 

At the same time, CEO Elon Musk has emphasized annual robot updates and transformative AI projects.

Overall, Tesla’s trajectory in 2026 increasingly hinges on execution in these non-vehicle segments as traditional EV volume growth slows. Investors are now awaiting first-quarter updates for clearer signals on the company’s AI-driven future.

Featured image via Shutterstock

Source: https://finbold.com/tesla-stock-set-for-more-pain-after-major-bearish-exposure/

Piyasa Fırsatı
Major Logosu
Major Fiyatı(MAJOR)
$0.06458
$0.06458$0.06458
+0.59%
USD
Major (MAJOR) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Paylaş
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Paylaş
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Paylaş
BitcoinEthereumNews2025/09/18 03:26